BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17610480)

  • 21. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
    Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
    J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
    Kim D; Jung WH; Koo JS
    Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.
    Martínez-Antón A; Debolós C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
    Clin Exp Allergy; 2006 Apr; 36(4):448-57. PubMed ID: 16630149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
    Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
    J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
    Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
    Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease.
    Caramori G; Di Gregorio C; Carlstedt I; Casolari P; Guzzinati I; Adcock IM; Barnes PJ; Ciaccia A; Cavallesco G; Chung KF; Papi A
    Histopathology; 2004 Nov; 45(5):477-84. PubMed ID: 15500651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.
    Elsheikh MN; Mahfouz ME
    Laryngoscope; 2006 Mar; 116(3):365-9. PubMed ID: 16540890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.
    Miyashita T; Murata K; Hoshino E; Nishiya H; Ono Y; Akaoka I; Kunii O
    Dig Dis Sci; 1999 Nov; 44(11):2231-4. PubMed ID: 10573367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
    Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL
    Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
    Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
    Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic mucin removal in patients with pseudomyxoma peritonei.
    Kotani Y; Shiota M; Umemoto M; Tobiume T; Koike E; Shimaoka M; Takahashi Y; Kanemura K; Ishizu A; Hoshiai H
    JSLS; 2009; 13(2):203-6. PubMed ID: 19660216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muc5b and Muc5ac are the major oligomeric mucins in equine airway mucus.
    Rousseau K; Kirkham S; McKane S; Newton R; Clegg P; Thornton DJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1396-404. PubMed ID: 17293373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair.
    Esquivel J; Sugarbaker PH
    Eur J Surg Oncol; 2001 Feb; 27(1):54-8. PubMed ID: 11237493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
    Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Henke MO; John G; Germann M; Lindemann H; Rubin BK
    Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.